IMB 101 - IMBiologics
Alternative Names: IMB-101 - IMBiologics; OX40LxTNFα bispecific antibody - IMBiologics; OXTIMALatest Information Update: 02 Jan 2024
At a glance
- Originator HK inno.N
- Class Anti-inflammatories; Bispecific antibodies
- Mechanism of Action OX40 ligand inhibitors; Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Rheumatoid arthritis